FDA Drug Recalls

Recalls / Class II

Class IID-1327-2020

Product

Sterile Curcumin, 4mg/mL, 10mL vial

Affected lot / code info
Lot #: 2H071219CCD, 2H0712019CCD, 2H07122019CCD, Exp. Date 7/12/2021

Why it was recalled

Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin

Recalling firm

Firm
BIOTA Biosciences LLC
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
1601 5th Ave Ste 1100, N/A, Seattle, Washington 98101-3603

Distribution

Quantity
N/A
Distribution pattern
Nationwide within the United States and New Zealand

Timeline

Recall initiated
2020-05-11
FDA classified
2020-06-19
Posted by FDA
2020-07-01
Terminated
2020-12-03
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1327-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls